Health Cor Management, L.P. Clovis Oncology, Inc. Transaction History

Health Cor Management, L.P.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$3.0 - $16.43 $4.47 Million - $24.5 Million	-1,491,376 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$3.93 - $15.35 $615,886 - $2.41 Million	-156,714 Reduced 9.51%	1,491,376 $5.86 Million
Q2 2019 Aug 14, 2019	BUY	$12.81 - $25.67 $3.2 Million - $6.41 Million	249,790 Added 17.86%	1,648,090 $24.5 Million
Q1 2019 May 15, 2019	BUY	$17.66 - $30.28 $24.7 Million - $42.3 Million	1,398,300 New	1,398,300 $34.7 Million
Q1 2018 May 15, 2018	SELL	$50.12 - $67.72 $48.8 Million - $65.9 Million	-973,840 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$57.69 - $84.58 $18.8 Million - $27.6 Million	326,420 Added 50.42%	973,840 $66.2 Million
Q3 2017 Nov 14, 2017	BUY	$67.17 - $84.81 $43.5 Million - $54.9 Million	647,420	647,420 $53.3 Million

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Health Cor Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Health Cor Management, L.P. with notifications on news.